Scripta Therapeutics
Biotechnology company developing longevity therapeutics focused on epigenetic reprogramming approaches to treat age-related diseases. Raised $12 million in seed funding in November 2025.
Location
Boston, Massachusetts, USA
Founded
2023
Investors
1
Categories
biotech, therapeutics, longevity, epigenetics
Notes
Scripta Therapeutics is a biotechnology company focused on developing longevity therapeutics. The company is working on novel approaches to address age-related diseases through epigenetic and cellular reprogramming technologies.
In November 2025, Scripta Therapeutics raised $12 million in seed funding to advance its longevity therapeutics programs. The company is backed by Apollo Health Ventures, which specializes in longevity and aging-related biotechnology investments.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Investor: Apollo Health Ventures
- Raised $12 million in seed funding (November 2025)
- Focus on longevity therapeutics
- Epigenetic reprogramming approach
- Boston, Massachusetts headquarters
- Early-stage company
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |